Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $96,495,000 across 23 holdings for the quarter ended 2016-06-30, in a 13F-HR filed 2016-08-12. Its ten largest share positions make up 85.26% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-16-019779

Period
2016-06-30
Reported value
$96.5M
Holdings
23
Top 10 weight
85.26%
New
2
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
Adverum Biotechnologies, In…new+1,102,735$3.48M
BCRXadded+442,161$1.26M
Alcobra Ltdadded+138,813$623K
AEGLEA BIOTHERAPEUTICS INCnew+6,000$29K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ANACOR PHARMACEUTICALS INCexited-140,756-$7.52M
AVALANCHE BIOTexited-1,102,735-$5.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2016

Share positions as resolved from 13F-HR 0000950123-16-019779, largest first. % of portfolio is the value over $96,495,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares; 2015Q3: 693,810 shares; 2015Q4: 463,643 shares; 2016Q1: 456,893 shares; 2016Q2: 456,893 shares 456,893$29.1M30.17%0
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares; 2015Q3: 1,095,734 shares; 2015Q4: 1,095,734 shares; 2016Q1: 1,095,734 shares; 2016Q2: 1,095,734 shares 1,095,734$19.8M20.5%0Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares; 2015Q3: 870,269 shares; 2015Q4: 611,010 shares; 2016Q1: 611,010 shares; 2016Q2: 611,010 shares 611,010$10.3M10.69%0Timeline
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares; 2015Q3: 500,000 shares; 2015Q4: 500,000 shares; 2016Q1: 500,000 shares; 2016Q2: 500,000 shares 500,000$5.37M5.57%0
ZAFGEN INCZAFGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 541,480 shares; 2015Q2: 541,480 shares; 2015Q3: 541,480 shares; 2015Q4: 541,480 shares; 2016Q1: 602,114 shares; 2016Q2: 602,114 shares 602,114$3.61M3.74%0
Adverum Biotechnologies, In…Adverum Biotechnologies, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: 1,102,735 shares 1,102,735$3.48M3.61%new
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,744,356 shares; 2015Q2: 373,686 shares; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 562,943 shares; 2016Q2: 1,005,104 shares 1,005,104$2.85M2.96%+442,161Timeline
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares; 2015Q3: 1,500,000 shares; 2015Q4: 484,500 shares; 2016Q1: 484,500 shares; 2016Q2: 623,313 shares 623,313$2.8M2.9%+138,813
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares; 2015Q3: 1,269,921 shares; 2015Q4: 849,921 shares; 2016Q1: 849,921 shares; 2016Q2: 849,921 shares 849,921$2.58M2.68%0
AXOVANT SCIENCES LTDAXOVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 184,110 shares; 2016Q2: 184,110 shares 184,110$2.36M2.45%0
AKARI THERAPEUTICS PLCAKARI THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 527,842 shares; 2015Q4: 158,352 shares; 2016Q1: 158,352 shares; 2016Q2: 158,352 shares 158,352$2.14M2.21%0
Cynapsus Therapeutics IncCynapsus Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 5,878,855 shares; 2015Q2: 367,427 shares; 2015Q3: 367,427 shares; 2015Q4: 110,226 shares; 2016Q1: 108,575 shares; 2016Q2: 108,575 shares 108,575$1.81M1.87%0
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 51,000 shares; 2016Q2: 51,000 shares 51,000$1.52M1.58%0Timeline
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares; 2015Q3: 703,730 shares; 2015Q4: 703,730 shares; 2016Q1: 796,550 shares; 2016Q2: 796,550 shares 796,550$1.51M1.57%0
EDGE THERAPEUTICS INCEDGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 135,000 shares; 2016Q1: 135,000 shares; 2016Q2: 135,000 shares 135,000$1.36M1.41%0
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: 10,789,324 shares; 2015Q3: 1,541,331 shares; 2015Q4: 462,399 shares; 2016Q1: 462,399 shares; 2016Q2: 462,399 shares 462,399$1.34M1.39%0
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 60,691 shares; 2016Q1: 72,990 shares; 2016Q2: 72,990 shares 72,990$1.21M1.25%0
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares; 2015Q3: 811,152 shares; 2015Q4: 90,000 shares; 2016Q1: 90,000 shares; 2016Q2: 90,000 shares 90,000$1.19M1.24%0Timeline
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares; 2015Q3: 451,400 shares; 2015Q4: 135,420 shares; 2016Q1: 135,420 shares; 2016Q2: 135,420 shares 135,420$917K0.95%0
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 75,000 shares; 2016Q1: 64,200 shares; 2016Q2: 64,200 shares 64,200$656K0.68%0Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 1,083,454 shares; 2015Q4: 52,500 shares; 2016Q1: 52,500 shares; 2016Q2: 52,500 shares 52,500$420K0.44%0Timeline
Sierra Oncology, Inc.Sierra Oncology, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 250,000 shares; 2015Q4: 75,000 shares; 2016Q1: 56,056 shares; 2016Q2: 56,056 shares 56,056$112K0.12%0
AEGLEA BIOTHERAPEUTICS INCAEGLEA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: 6,000 shares 6,000$29K0.03%new

Sold out in Q2 2016

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ANACOR PHARMACEUTICALS INCANACOR PHARMACEUTICALS INC140,756$7.52Mshares
AVALANCHE BIOTAVALANCHE BIOT1,102,735$5.7Mshares

How Q2 2016 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-16-019779 base2016-08-12acceptance time not in the bulk data set